Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
Scandinavian Journal of Infectious Diseases
|
September 18, 2014
Efficacy and safety of switching to raltegravir plus atazanavir dual therapy in pretreated HIV-1-infected patients over 144 weeks: a cohort study
Pierre Gantner, Christine Koeppel, Marialuisa Partisani, et al.
Journal of Medical Virology
|
June 16, 2017
Interlaboratory quality control of total HIV-1 DNA load measurement for multicenter reservoir studies
Pierre Gantner, Adeline Mélard, Florence Damond, et al.
The Journal of Antimicrobial Chemotherapy
|
December 16, 2017
Dolutegravir reshapes the genetic diversity of HIV-1 reservoirs
Pierre Gantner, Guinevere Q Lee, David Rey, et al.
Plos One
|
April 19, 2019
Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection
Pierre Gantner, Laurent Cotte, Clotilde Allavena, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
February 13, 2024
Impact of anti-HDV reflex testing at HBs antigen positive discovery in a single center France: Support for primary HDV screening in France
Assilina Parfut, Simona Tripon, Pierre Gantner, et al.
Journal of Neurovirology
|
October 31, 2024
Incidence of tick-borne encephalitis (TBE) in the pediatric population at the University Hospitals of Strasbourg (HUS) and characterization of confirmed cases
Assilina Parfut, Ludovic Glady, Gaëlle Gonzalez, et al.
International Journal of Biological Macromolecules
|
April 16, 2025
Potent HIV-1 miniprotein inhibitors targeting highly conserved gp41 epitopes
Daniel Polo-Megías, Mario Cano-Muñoz, Pierre Gantner, et al.
Plos One
|
April 25, 2019
"Real life" use of raltegravir during pregnancy in France: The Coferal-IMEA048 cohort study
Pierre Gantner, Babacar Sylla, Laurence Morand-Joubert, et al.
The Journal of Antimicrobial Chemotherapy
|
December 18, 2015
Drug resistance and tropism as markers of the dynamics of HIV-1 DNA quasispecies in blood cells of heavily pretreated patients who achieved sustained virological suppression
Pierre Gantner, Laurence Morand-Joubert, Charlotte Sueur, et al.
Immunity
|
February 22, 2023
HIV rapidly targets a diverse pool of CD4<sup>+</sup> T cells to establish productive and latent infections
Pierre Gantner, Supranee Buranapraditkun, Amélie Pagliuzza, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
Scandinavian Journal of Infectious Diseases
|
September 18, 2014
Efficacy and safety of switching to raltegravir plus atazanavir dual therapy in pretreated HIV-1-infected patients over 144 weeks: a cohort study
Pierre Gantner, Christine Koeppel, Marialuisa Partisani, et al.
Journal of Medical Virology
|
June 16, 2017
Interlaboratory quality control of total HIV-1 DNA load measurement for multicenter reservoir studies
Pierre Gantner, Adeline Mélard, Florence Damond, et al.
The Journal of Antimicrobial Chemotherapy
|
December 16, 2017
Dolutegravir reshapes the genetic diversity of HIV-1 reservoirs
Pierre Gantner, Guinevere Q Lee, David Rey, et al.
Plos One
|
April 19, 2019
Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection
Pierre Gantner, Laurent Cotte, Clotilde Allavena, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
February 13, 2024
Impact of anti-HDV reflex testing at HBs antigen positive discovery in a single center France: Support for primary HDV screening in France
Assilina Parfut, Simona Tripon, Pierre Gantner, et al.
Journal of Neurovirology
|
October 31, 2024
Incidence of tick-borne encephalitis (TBE) in the pediatric population at the University Hospitals of Strasbourg (HUS) and characterization of confirmed cases
Assilina Parfut, Ludovic Glady, Gaëlle Gonzalez, et al.
International Journal of Biological Macromolecules
|
April 16, 2025
Potent HIV-1 miniprotein inhibitors targeting highly conserved gp41 epitopes
Daniel Polo-Megías, Mario Cano-Muñoz, Pierre Gantner, et al.
Plos One
|
April 25, 2019
"Real life" use of raltegravir during pregnancy in France: The Coferal-IMEA048 cohort study
Pierre Gantner, Babacar Sylla, Laurence Morand-Joubert, et al.
The Journal of Antimicrobial Chemotherapy
|
December 18, 2015
Drug resistance and tropism as markers of the dynamics of HIV-1 DNA quasispecies in blood cells of heavily pretreated patients who achieved sustained virological suppression
Pierre Gantner, Laurence Morand-Joubert, Charlotte Sueur, et al.
Immunity
|
February 22, 2023
HIV rapidly targets a diverse pool of CD4<sup>+</sup> T cells to establish productive and latent infections
Pierre Gantner, Supranee Buranapraditkun, Amélie Pagliuzza, et al.
Page
of 4